Conversation with The Cancer LetterReal-world Evidence RWD company documents baseline trends in women’s cancers before Trump’s policy changes January 24, 2025Vol.51 No.03By Claire Marie Porter
Conversation with The Cancer Letter After 25 years as FDA’s chief cancer strategist, Richard Pazdur reflects on opportunities for change at the agency January 10, 2025Vol.51 No.01By Paul Goldberg
Conversation with The Cancer Letter Brian Druker steps down as CEO of OHSU Knight Cancer Center December 06, 2024Vol.50 No.45By Paul Goldberg
Conversation with The Cancer Letter 2024 Harry Hynes Award winner Judith Hopkins on being a doctor in 1977, mentorship, and the benefits of community practice November 08, 2024Vol.50 No.42By Jacquelyn Cobb
Conversation with The Cancer Letter Iowa’s Mark Burkard sees a role for data science in bringing clinical trials to rural clinicsThe state has the second highest (and rising) cancer rates in the U.S. November 01, 2024Vol.50 No.41By Paul Goldberg
Conversation with The Cancer Letter Undergrad intern at MSK poses a profound question: What if Henrietta Lacks had a Black doctor? October 04, 2024Vol.50 No.37By Claire Marie Porter
Cancer History ProjectConversation with The Cancer Letter Tom Lynch reflects on discovery of the EGFR mutations’ role in lung cancer October 04, 2024Vol.50 No.37By Paul Goldberg and McKenzie Prillaman
Conversation with The Cancer LetterFree A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease September 17, 2024Vol.50 No.35By Paul Goldberg
Conversation with The Cancer Letter Lei Zheng got his PhD in San Antonio; now he returns as cancer center director at Mays September 06, 2024Vol.50 No.33By Paul Goldberg
Cancer History ProjectConversation with The Cancer LetterFree Lung cancer couldn’t slow down physician and athlete Lawrence Phillips September 06, 2024Vol.50 No.33By Deborah Doroshow and McKenzie Prillaman
